Contents
Issue 146 • September 2024
In association with
In Depth
Pharma's green shift: dry powder inhalers promise lower emissions
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
What is the pharmacy of the future?
Obesity trial surge puts the focus back on decentralisation
A slow start for self-amplifying mRNA vaccines
For pharma companies, the possibilities of green chemistry are huge
Will the tide turn for the wave of pharma layoffs?